Literature DB >> 19869902

DECOMPOSITION OF THE CAPSULAR POLYSACCHARIDE OF PNEUMOCOCCUS TYPE III BY A BACTERIAL ENZYME.

R Dubos1, O T Avery.   

Abstract

1. An organism has been isolated from peat soil which decomposes the specific capsular polysaccharide of Type III Pneumococcus. 2. The isolation has been made possible by the use of a synthetic mineral medium containing the specific polysaccharide as sole source of carbon. By repeated transfers in this medium the potential capacity of the organism to decompose the specific substance has been progressively increased. 3. The organism is a pleomorphic bacillus, motile and spore-bearing, exhibiting metachromatic granules; its reaction to the Gram stain varies according to the medium on which it is grown. It is strictly aerobic and grows well in plain broth and peptone solutions; it does not produce gas in any media and it forms small amounts of acid only on dextrin, galactose, lactose, salicin, and trehalose; its growth is inhibited by glucose. 4. The organism decomposes the capsular polysaccharide of Type III Pneumococcus aerobically, between pH 6.2 and 7.8, at room temperature and at 37.5 degrees C., but not at 54 degrees C. The decomposition of the specific substance is inhibited by the presence in the medium of other nutrients, such as peptones, which act as a more readily available source of energy. The action of the organism is specific; it does not attack the soluble specific substance of Type I or Type II Pneumococcus, nor any of the other bacterial polysaccharides thus far tested. 5. The organism possesses an endocellular enzyme. This enzyme has been extracted by autolysis of the bacterial cells; in sterile solution it exhibits the same specific action as do the organisms from which it is derived, decomposing only the capsular polysaccharide of Type III Pneumococcus. 6. This enzyme decomposes the Type III specific polysaccharide under anaerobic as well as under aerobic conditions; it is inactivated at 60-65 degrees C.; the rate of decomposition of the specific substance is not affected by the presence of normal serum. 7. There exists a quantitative relationship between the total amount of specific substance decomposed and the amount of enzyme preparation used; the existence of this relation makes it possible to express the activity of a given enzyme preparation in terms of the minimal amount required for the complete decomposition of a given amount of specific substance. 8. The specific decomposition of the capsular polysaccharide of Type III Pneumococcus, by the organism as well as by the enzyme it produces, illustrates once more the specificity of the types of Pneumococcus and confirms the fact that the capsular polysaccharides, and not some impurities carried along with them, are responsible for type specificity.

Entities:  

Year:  1931        PMID: 19869902      PMCID: PMC2132046          DOI: 10.1084/jem.54.1.51

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  7 in total

1.  THE DECOMPOSITION OF CELLULOSE BY AEROBIC BACTERIA.

Authors:  R J Dubos
Journal:  J Bacteriol       Date:  1928-04       Impact factor: 3.490

2.  THE SPECIFIC ACTION OF A BACTERIAL ENZYME ON PNEUMOCOCCI OF TYPE III.

Authors:  O T Avery; R Dubos
Journal:  Science       Date:  1930-08-08       Impact factor: 47.728

3.  THE SOLUBLE SPECIFIC SUBSTANCE OF PNEUMOCOCCUS : SECOND PAPER.

Authors:  M Heidelberger; O T Avery
Journal:  J Exp Med       Date:  1924-08-31       Impact factor: 14.307

4.  VARIATION AND TYPE SPECIFICITY IN THE BACTERIAL SPECIES HEMOPHILUS INFLUENZAE.

Authors:  M Pittman
Journal:  J Exp Med       Date:  1931-03-31       Impact factor: 14.307

5.  THE SOLUBLE SPECIFIC SUBSTANCE OF A STRAIN OF FRIEDLANDER'S BACILLUS : PAPER I.

Authors:  M Heidelberger; W F Goebel; O T Avery
Journal:  J Exp Med       Date:  1925-10-31       Impact factor: 14.307

6.  A "SOLUBLE SPECIFIC SUBSTANCE" DERIVED FROM GUM ARABIC.

Authors:  M Heidelberger; O T Avery; W F Goebel
Journal:  J Exp Med       Date:  1929-04-30       Impact factor: 14.307

7.  THE SOLUBLE SPECIFIC SUBSTANCE OF FRIEDLANDER'S BACILLUS : III. ON THE ISOLATION AND PROPERTIES OF THE SPECIFIC CARBOHYDRATES FROM TYPES A AND C FRIEDLANDER BACILLUS.

Authors:  W F Goebel; O T Avery
Journal:  J Exp Med       Date:  1927-09-30       Impact factor: 14.307

  7 in total
  26 in total

1.  STUDIES ON THE CHEMICAL NATURE OF THE SUBSTANCE INDUCING TRANSFORMATION OF PNEUMOCOCCAL TYPES : INDUCTION OF TRANSFORMATION BY A DESOXYRIBONUCLEIC ACID FRACTION ISOLATED FROM PNEUMOCOCCUS TYPE III.

Authors:  O T Avery; C M Macleod; M McCarty
Journal:  J Exp Med       Date:  1944-02-01       Impact factor: 14.307

Review 2.  Immunogenicity and immunochemistry of Streptococcus pneumoniae capsular polysaccharides.

Authors:  J E van Dam; A Fleer; H Snippe
Journal:  Antonie Van Leeuwenhoek       Date:  1990-06       Impact factor: 2.271

3.  Parenteral Administration of Capsule Depolymerase EnvD Prevents Lethal Inhalation Anthrax Infection.

Authors:  David Negus; Julia Vipond; Graham J Hatch; Emma L Rayner; Peter W Taylor
Journal:  Antimicrob Agents Chemother       Date:  2015-10-05       Impact factor: 5.191

Review 4.  Antimicrobial bacteriophage-derived proteins and therapeutic applications.

Authors:  Dwayne R Roach; David M Donovan
Journal:  Bacteriophage       Date:  2015-06-23

5.  Identification and characterization of the Streptococcus pneumoniae type 3 capsule-specific glycoside hydrolase of Paenibacillus species 32352.

Authors:  Dustin R Middleton; Xing Zhang; Paeton L Wantuch; Ahmet Ozdilek; Xinyue Liu; Rachel LoPilato; Nikhil Gangasani; Robert Bridger; Lance Wells; Robert J Linhardt; Fikri Y Avci
Journal:  Glycobiology       Date:  2018-02-01       Impact factor: 4.313

Review 6.  A century of the phage: past, present and future.

Authors:  George P C Salmond; Peter C Fineran
Journal:  Nat Rev Microbiol       Date:  2015-11-09       Impact factor: 60.633

7.  Enzymatic Hydrolysis of Pneumococcal Capsular Polysaccharide Renders the Bacterium Vulnerable to Host Defense.

Authors:  Dustin R Middleton; Amy V Paschall; Jeremy A Duke; Fikri Y Avci
Journal:  Infect Immun       Date:  2018-07-23       Impact factor: 3.441

8.  Prevention and cure of systemic Escherichia coli K1 infection by modification of the bacterial phenotype.

Authors:  Naseem Mushtaq; Maria B Redpath; J Paul Luzio; Peter W Taylor
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

9.  Characterization of the β-glucuronidase Pn3Pase as the founding member of glycoside hydrolase family GH169.

Authors:  Paeton L Wantuch; Satya Jella; Jeremy A Duke; Jarrod J Mousa; Bernard Henrissat; John Glushka; Fikri Y Avci
Journal:  Glycobiology       Date:  2021-04-01       Impact factor: 4.313

10.  Characterisation of Bacteriophage-Encoded Depolymerases Selective for Key Klebsiella pneumoniae Capsular Exopolysaccharides.

Authors:  George Blundell-Hunter; Mark C Enright; David Negus; Matthew J Dorman; Gemma E Beecham; Derek J Pickard; Phitchayapak Wintachai; Supayang P Voravuthikunchai; Nicholas R Thomson; Peter W Taylor
Journal:  Front Cell Infect Microbiol       Date:  2021-06-18       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.